Physiology of male gonadotropic axis and disorders of sex development

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
bookPart
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Citação
de Mendonca, B. B.; Costa, E. M. F.. Physiology of male gonadotropic axis and disorders of sex development. In: . TESTOSTERONE: FROM BASIC TO CLINICAL ASPECTS: SPRINGER INTERNATIONAL PUBLISHING, 2017. p.75-96.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The hypothalamic-pituitary-testicular axis is activated in the third trimester of intrauterine life and during the neonatal period. Fetus testes differentiate by the end of the fifth embryonic week, before the gonadotrophs are functionally active. Therefore, GnRH deficiency does not affect male sexual differentiation. The 46,XY disorders of sex development (DSD) are characterized by atypical or female external genitalia, caused by incomplete intrauterine masculinization, in the presence or absence of Müllerian structures. 46,XY DSD result from decreased production of testosterone, decreased conversion of testosterone into dihydrotestosterone, or from impairment of their peripheral action. Under histological analysis, testicular tissue in patients with 46,XY DSD can be absent, partially or completely dysgenetic, or almost normal. Taking in account testosterone levels, the etiology of the 46,XY DSD can be classified into two large groups: low testosterone secretion and normal or high testosterone secretion. Most patients with DSD present with atypical genitalia and their sex assignment may be a complex procedure. The choice of male sex-of rearing in 46,XY babies with atypical genitalia is a challenging situation. The participation of a multidisciplinary team is essential during this process and the immediate identification of a molecular defect causing the disorder might aid in this decision. © Springer International Publishing Switzerland 2017.
Palavras-chave
46,XY DSD, AMH, FSH, GnRH, Inhibin, LH, Male gonadotropic axis, Testosterone
Referências
  1. Terasawa, E., Fernandez, D.L., Neurobiological mechanisms of the onset of puberty in primates (2001) Endocr Rev, 22 (1), pp. 111-151
  2. Petersen, C., Soder, O., The sertoli cell--a hormonal target and ‘super’ nurse for germ cells that determines testicular size (2006) Horm Res, 66 (4), pp. 153-161
  3. Rey, R.A., Grinspon, R.P., Gottlieb, S., Pasqualini, T., Knoblovits, P., Aszpis, S., Male hypogonadism: An extended classification based on a developmental, endocrine physiology-based approach (2013) Andrology, 1 (1), pp. 3-16
  4. Silveira, L.G., Latronico, A.C., Seminara, S.B., Kisspeptin and clinical disorders (2013) Adv Exp Med Biol, 784, pp. 187-199
  5. Abreu, A.P., Dauber, A., Macedo, D.B., Noel, S.D., Brito, V.N., Gill, J.C., Central precocious puberty caused by mutations in the imprinted gene MKRN3 (2013) N Engl J Med, 368 (26), pp. 2467-2475
  6. Seminara, S.B., Messager, S., Chatzidaki, E.E., Thresher, R.R., Acierno, J.S., Jr., Shagoury, J.K., The GPR54 gene as a regulator of puberty (2003) N Engl J Med, 349 (17), pp. 1614-1627
  7. De Roux, N., Genin, E., Carel, J.C., Matsuda, F., Chaussain, J.L., Milgrom, E., Hypogonadotropic hypogonadism due to loss of function of the KiSSl-derived peptide receptor GPR54 (2003) Proc Natl Acad Sci U S A, 100 (19), pp. 10972-10976
  8. Pinilla, L., Aguilar, E., Dieguez, C., Millar, R.P., Tena-Sempere, M., Kisspeptins and reproduction: Physiological roles and regulatory mechanisms (2012) Physiol Rev, 92 (3), pp. 1235-1316
  9. Skorupskaite, K., George, J.T., Erson, R.A., The kisspeptin-GnRH pathway in human reproductive health and disease (2014) Hum Reprod Update, 20 (4), pp. 485-500
  10. Sherins, R.J., Loriaux, D.L., Studies of the role of sex steroids in the feedback control of FSH concentrations in men (1973) J Clin Endocrinol Metab, 36 (5), pp. 886-893
  11. Santen, R.J., Bardin CW. Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms (1973) J Clin Invest, 52 (10), pp. 2617-2628
  12. Tilbrook, A.J., De Kretser, D.M., Cummins, J.T., Clarke, I.J., The negative feedback effects of testicular steroids are predominantly at the hypothalamus in the ram (1991) Endocrinology, 129 (6), pp. 3080-3092
  13. Hayes, F.J., Seminara, S.B., Decruz, S., Boepple, P.A., Crowley, W.F., Jr., Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback (2000) J Clin Endocrinol Metab, 85 (9), pp. 3027-3035
  14. George, J.T., Veldhuis, J.D., Roseweir, A.K., Newton, C.L., Faccenda, E., Millar, R.P., Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men (2011) J Clin Endocrinol Metab, 96 (8), pp. E1228-E1E36
  15. Navarro, V.M., Castellano, J.M., Fernandez-Fernandez, R., Tovar, S., Roa, J., Mayen, A., Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat (2005) Endocrinology, 146 (4), pp. 1689-1697
  16. Thompson, E.L., Patterson, M., Murphy, K.G., Smith, K.L., Dhillo, W.S., Todd, J.F., Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis (2004) J Neuroendocrinol, 16 (10), pp. 850-858
  17. Young, J., George, J.T., Tello, J.A., Francou, B., Bouligand, J., Guiochon-Mantel, A., Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: Physiological, pathophysiological and therapeutic implications (2013) Neuroendocrinology, 97 (2), pp. 193-202
  18. Decker, M.H., Loriaux, D.L., Cutler, G.B., Jr., A seminiferous tubular factor is not obligatory for regulation of plasma follicle-stimulating hormone in the rat (1981) Endocrinology, 108 (3), pp. 1035-1039
  19. De Kretser, D.M., Robertson, D.M., The isolation and physiology of inhibin and related proteins (1989) Biol Reprod, 40 (1), pp. 33-47
  20. Forage, R.G., Ring, J.M., Brown, R.W., Mc Inerney, B.V., Cobon, G.S., Gregson, R.P., Cloning and sequence analysis of cDNA species coding for the two subunits of inhibin from bovine follicular fluid (1986) Proc Natl Acad Sci U S A, 83 (10), pp. 3091-3095
  21. Ling, N., Ying, S.Y., Ueno, N., Shimasaki, S., Esch, F., Hotta, M., Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin (1986) Nature, 321 (6072), pp. 779-782
  22. Vale, W., Rivier, J., Vaughan, J., Mc Clintock, R., Corrigan, A., Woo, W., Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid (1986) Nature, 321 (6072), pp. 776-779
  23. Ueno, N., Ling, N., Ying, S.Y., Esch, F., Shimasaki, S., Guillemin, R., Isolation and partial characterization of follistatin: A single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone (1987) Proc Natl Acad Sci U S A, 84 (23), pp. 8282-8286
  24. Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., Sugino, H., Activin-binding protein from rat ovary is follistatin (1990) Science, 247 (4944), pp. 836-838
  25. Sharpe, R.M., Turner, K.J., Mc Kinnell, C., Groome, N.P., Atanassova, N., Millar, M.R., Inhibin B levels in plasma of the male rat from birth to adulthood: Effect of experimental manipulation of Sertoli cell number (1999) J Androl, 20 (1), pp. 94-101
  26. Anderson, R.A., Wallace, E.M., Groome, N.P., Bellis, A.J., Wu, F.C., Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone (1997) Hum Reprod, 12 (4), pp. 746-751
  27. Krummen, L.A., Toppari, J., Kim, W.H., Morelos, B.S., Ahmad, N., Swerdloff, R.S., Regulation of testicular inhibin subunit messenger ribonucleic acid levels in vivo: Effects of hypophysectomy and selective follicle-stimulating hormone replacement (1989) Endocrinology, 125 (3), pp. 1630-1637
  28. Wallace, E.M., Groome, N.P., Riley, S.C., Parker, A.C., Wu, F.C., Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: A prospective longitudinal study (1997) J Clin Endocrinol Metab, 82 (9), pp. 3111-3115
  29. Mather, J.P., Attie, K.M., Woodruff, T.K., Rice, G.C., Phillips, D.M., Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis (1990) Endocrinology, 127 (6), pp. 3206-3214
  30. Archambeault, D.R., Yao, H.H., Activin A, a product of fetal Leydig cells, is a unique paracrine regulator of Sertoli cell proliferation and fetal testis cord expansion (2010) Proc Natl Acad Sci U S A, 107 (23), pp. 10526-10531
  31. Mendis, S.H., Meachem, S.J., Sarraj, M.A., Loveland, K.L., Activin A balances Sertoli and germ cell proliferation in the fetal mouse testis (2011) Biol Reprod, 84 (2), pp. 379-391
  32. De Winter, J.P., Themmen, A.P., Hoogerbrugge, J.W., Klaij, I.A., Grootegoed, J.A., De Jong, F.H., Activin receptor mRNA expression in rat testicular cell types (1992) Mol Cell Endocrinol, 83 (1), pp. R1-R8
  33. Meinhardt, A., O’bryan, M.K., Mc Farlane, J.R., Loveland, K.L., Mallidis, C., Foulds, L.M., Localization of follistatin in the rat testis (1998) J Reprod Fertil, 112 (2), pp. 233-241
  34. Tilbrook, A.J., De Kretser, D.M., Dunshea, F.R., Klein, R., Robertson, D.M., Clarke, I.J., The testis is not the major source of circulating follistatin in the ram (1996) J Endocrinol, 149 (1), pp. 55-63
  35. Ramaswamy, S., Pohl, C.R., Mc Neilly, A.S., Winters, S.J., Plant, T.M., The time course of follicle-stimulating hormone suppression by recombinant human inhibin A in the adult male rhesus monkey (Macaca mulatta) (1998) Endocrinology, 139 (8), pp. 3409-3415
  36. Tilbrook, A.J., De Kretser, D.M., Clarke, I.J., Human Recombinant Inhibin, A., Suppresses plasma follicle-stimulating hormone to intact levels but has no effect on luteinizing hormone in castrated rams (1993) Biol Reprod, 49 (4), pp. 779-788
  37. Matzuk, M.M., Kumar, T.R., Bradley, A., Different phenotypes for mice deficient in either activins or activin receptor type II (1995) Nature, 374 (6520), pp. 356-360
  38. Chemes, H.E., Dym, M., Raj, H.G., Hormonal regulation of Sertoli cell differentiation (1979) Biol Reprod, 21 (1), pp. 251-262
  39. Josso, N., Picard, J.Y., Rey, R., Di Clemente, N., Testicular anti-Mullerian hormone: History, genetics, regulation and clinical applications (2006) Pediatr Endocrinol Rev, 3 (4), pp. 347-358
  40. Rey, R.A., Musse, M., Venara, M., Chemes, H.E., Ontogeny of the androgen receptor expression in the fetal and postnatal testis: Its relevance on Sertoli cell maturation and the onset of adult spermatogenesis (2009) Microsc Res Tech, 72 (11), pp. 787-795
  41. Young, J., Rey, R., Couzinet, B., Chanson, P., Josso, N., Schaison, G., Antimullerian hormone in patients with hypogonadotropic hypogonadism (1999) J Clin Endocrinol Metab, 84 (8), pp. 2696-2699
  42. Jensen, T.K., Ersson, A.M., Hjollund, N.H., Scheike, T., Kolstad, H., Giwercman, A., Inhibin B as a serum marker of spermatogenesis: Correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men (1997) J Clin Endocrinol Metab, 82 (12), pp. 4059-4063
  43. Mendonca, B.B., Domenice, S., Arnhold, I.J., Costa, E.M., 46,XY disorders of sex development (DSD) (2009) Clin Endocrinol (Oxf), 70 (2), pp. 173-187
  44. Maclaughlin, D.T., Donahoe, P.K., Sex determination and differentiation (2004) N Engl J Med, 350 (4), pp. 367-378
  45. Achermann, J.C., Domenice, S., Bachega, T.A., Nishi, M.Y., Mendonca, B.B., Disorders of sex development: Effect of molecular diagnostics (2015) Nat Rev Endocrinol, 11 (8), pp. 478-488
  46. New, M.I., Lekarev, O., Parsa, A., Yuen, T.T., O’malley, B.W., Hammer, G.D., (2014) Genetic Steroid Disorders, 13, p. 392. , Amsterdam: Elsevier
  47. Grino, P.B., Griffin, J.E., Wilson, J.D., Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone (1990) Endocrinology, 126 (2), pp. 1165-1172
  48. Ostrer, H., Disorders of sex development (DSDs): An update (2014) J Clin Endocrinol Metab, 99 (5), pp. 1503-1509
  49. Berkovitz, G.D., Fechner, P.Y., Zacur, H.W., Rock, J.A., Snyder, H.M., III, Migeon, C.J., Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: Its relevance to the understanding of sex differentiation (1991) Medicine (Baltimore), 70 (6), pp. 375-383
  50. Arnhold, I.J., De Mendonca, B.B., Toledo, S.P., Madureira, G., Nicolau, W., Bisi, H., Leydig cell hypoplasia causing male pseudohermaphroditism: Case report and review of the literature (1987) Rev Hosp Clin Fac Med Sao Paulo, 42 (5), pp. 227-232
  51. Arnhold, I.J., Mendonca, B.B., Bloise, W., Toledo, S.P., Male pseudohermaphroditism resulting from Leydig cell hypoplasia (1985) J Pediatr, 106 (6), p. 1057
  52. Latronico, A.C., Anasti, J., Arnhold, I.J., Rapaport, R., Mendonca, B.B., Bloise, W., Brief report: Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene (1996) N Engl J Med, 334 (8), pp. 507-512
  53. Toledo, S.P., Arnhold, I.J., Luthold, W., Russo, E.M., Saldanha, P.H., Leydig cell hypoplasia determining familial hypergonadotropic hypogonadism (1985) Prog Clin Biol Res, 200, pp. 311-314
  54. Tint, G.S., Irons, M., Elias, E.R., Batta, A.K., Frieden, R., Chen, T.S., Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome (1994) N Engl J Med, 330 (2), pp. 107-113
  55. Miller, W.L., Molecular biology of steroid hormone synthesis (1988) Endocr Rev, 9 (3), pp. 295-318
  56. Geller, D.H., Auchus, R.J., Miller, W.L., P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5 (1999) Mol Endocrinol, 13 (1), pp. 167-175
  57. Andersson, S., Moghrabi, N., Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases (1997) Steroids, 62 (1), pp. 143-147
  58. Jenkins, E.P., Ersson, S., Imperato-Mc ginley, J., Wilson, J.D., Russell, D.W., Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase (1992) J Clin Invest, 89 (1), pp. 293-300
  59. Thigpen, A.E., Davis, D.L., Milatovich, A., Mendonca, B.B., Imperato-Mc ginley, J., Griffin, J.E., Molecular genetics of steroid 5 alpha-reductase 2 deficiency (1992) J Clin Invest, 90 (3), pp. 799-809
  60. Chavez, B., Valdez, E., Vilchis, F., Uniparental disomy in steroid 5alpha-reductase 2 deficiency (2000) J Clin Endocrinol Metab, 85 (9), pp. 3147-3150
  61. Mendonca, B.B., Inacio, M., Costa, E.M., Arnhold, I.J., Silva, F.A., Nicolau, W., Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management (1996) Medicine (Baltimore), 75 (2), pp. 64-76
  62. Hughes, I.A., Davies, J.D., Bunch, T.I., Pasterski, V., Mastroyannopoulou, K., Macdougall, J., Androgen insensitivity syndrome (2012) Lancet, 380 (9851), pp. 1419-1428
  63. Hannema, S.E., Scott, I.S., Rajpert-De Meyts, E., Skakkebaek, N.E., Coleman, N., Hughes, I.A., Testicular development in the complete androgen insensitivity syndrome (2006) J Pathol, 208 (4), pp. 518-527
  64. Cools, M., Van Aerde, K., Kersemaekers, A.M., Boter, M., Drop, S.L., Wolffenbuttel, K.P., Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes (2005) J Clin Endocrinol Metab, 90 (9), pp. 5295-5303
  65. Zuccarello, D., Ferlin, A., Vinanzi, C., Prana, E., Garolla, A., Callewaert, L., Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility (2008) Clin Endocrinol (Oxf), 68 (4), pp. 580-588
  66. Wang, R.S., Yeh, S., Tzeng, C.R., Chang, C., Androgen receptor roles in spermatogenesis and fertility: Lessons from testicular cell-specific androgen receptor knockout mice (2009) Endocr Rev, 30 (2), pp. 119-132
  67. Ahmed, S.F., Cheng, A., Dovey, L., Hawkins, J.R., Martin, H., Rowland, J., Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome (2000) J Clin Endocrinol Metab, 85 (2), pp. 658-665
  68. Melo, K.F., Mendonca, B.B., Billerbeck, A.E., Costa, E.M., Inacio, M., Silva, F.A., Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: Five novel mutations in the androgen receptor gene (2003) J Clin Endocrinol Metab, 88 (7), pp. 3241-3250
  69. Mendonca, B.B., Inacio, M., Arnhold, I.J., Costa, E.M., Bloise, W., Martin, R.M., Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management (2000) Medicine (Baltimore), 79 (5), pp. 299-309
  70. Sircili, M.H., E Silva, F.A., Costa, E.M., Brito, V.N., Arnhold, I.J., Denes, F.T., Long-term surgical outcome of masculinizing genitoplasty in large cohort of patients with disorders of sex development (2010) J Urol, 184 (3), pp. 1122-1127